American Bio Medica Corporation (ABMC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 1.26 Million USD | -32.61% |
| 2021 | 1.88 Million USD | -2.23% |
| 2020 | 1.92 Million USD | -7.31% |
| 2019 | 2.07 Million USD | -16.04% |
| 2018 | 2.47 Million USD | -14.39% |
| 2017 | 2.89 Million USD | -14.24% |
| 2016 | 3.37 Million USD | -11.22% |
| 2015 | 3.79 Million USD | -6.89% |
| 2014 | 4.07 Million USD | -17.88% |
| 2013 | 4.96 Million USD | 3.91% |
| 2012 | 4.77 Million USD | -15.21% |
| 2011 | 5.63 Million USD | -6.3% |
| 2010 | 6.01 Million USD | -14.56% |
| 2009 | 7.04 Million USD | -22.94% |
| 2008 | 9.13 Million USD | -0.15% |
| 2007 | 9.15 Million USD | 1.47% |
| 2006 | 9.01 Million USD | 13.59% |
| 2005 | 7.93 Million USD | -5.22% |
| 2004 | 8.37 Million USD | 23.56% |
| 2003 | 6.77 Million USD | 20.01% |
| 2002 | 5.64 Million USD | 11.05% |
| 2001 | 5.08 Million USD | 0.95% |
| 2000 | 5.03 Million USD | 13.6% |
| 1999 | 4.43 Million USD | -17.87% |
| 1998 | 5.4 Million USD | 31.49% |
| 1997 | 4.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 659 Thousand USD | -48.07% |
| 2023 Q2 | - USD | -100.0% |
| 2022 FY | 1.26 Million USD | -32.61% |
| 2022 Q1 | 1.56 Million USD | -16.89% |
| 2022 Q2 | 1.25 Million USD | -19.74% |
| 2022 Q3 | 1.17 Million USD | -6.29% |
| 2022 Q4 | 1.26 Million USD | 7.82% |
| 2021 FY | 1.88 Million USD | -2.23% |
| 2021 Q1 | 1.76 Million USD | -8.26% |
| 2021 Q2 | 1.64 Million USD | -6.96% |
| 2021 Q3 | 2.27 Million USD | 38.38% |
| 2021 Q4 | 1.88 Million USD | -17.23% |
| 2020 Q4 | 1.92 Million USD | 0.26% |
| 2020 FY | 1.92 Million USD | -7.31% |
| 2020 Q2 | 2.31 Million USD | -18.2% |
| 2020 Q3 | 1.92 Million USD | -16.84% |
| 2020 Q1 | 2.82 Million USD | 35.9% |
| 2019 Q2 | 2.16 Million USD | -6.52% |
| 2019 FY | 2.07 Million USD | -16.04% |
| 2019 Q1 | 2.31 Million USD | -6.42% |
| 2019 Q4 | 2.07 Million USD | -7.48% |
| 2019 Q3 | 2.24 Million USD | 3.74% |
| 2018 Q1 | 2.87 Million USD | -0.48% |
| 2018 Q3 | 2.8 Million USD | 1.15% |
| 2018 Q2 | 2.77 Million USD | -3.51% |
| 2018 Q4 | 2.47 Million USD | -11.86% |
| 2018 FY | 2.47 Million USD | -14.39% |
| 2017 Q4 | 2.89 Million USD | -8.02% |
| 2017 Q1 | 3.27 Million USD | -2.76% |
| 2017 Q3 | 3.14 Million USD | 0.26% |
| 2017 FY | 2.89 Million USD | -14.24% |
| 2017 Q2 | 3.13 Million USD | -4.36% |
| 2016 Q1 | 3.63 Million USD | -4.19% |
| 2016 Q3 | 3.54 Million USD | -1.2% |
| 2016 Q4 | 3.37 Million USD | -5.02% |
| 2016 FY | 3.37 Million USD | -11.22% |
| 2016 Q2 | 3.59 Million USD | -1.26% |
| 2015 FY | 3.79 Million USD | -6.89% |
| 2015 Q4 | 3.79 Million USD | -9.94% |
| 2015 Q1 | 4.25 Million USD | 4.24% |
| 2015 Q2 | 4.42 Million USD | 4.19% |
| 2015 Q3 | 4.21 Million USD | -4.81% |
| 2014 Q1 | 4.74 Million USD | -4.49% |
| 2014 FY | 4.07 Million USD | -17.88% |
| 2014 Q2 | 4.39 Million USD | -7.44% |
| 2014 Q3 | 4.33 Million USD | -1.18% |
| 2014 Q4 | 4.07 Million USD | -5.99% |
| 2013 FY | 4.96 Million USD | 3.91% |
| 2013 Q1 | 5.15 Million USD | 7.93% |
| 2013 Q2 | 5.26 Million USD | 2.09% |
| 2013 Q3 | 4.52 Million USD | -14.07% |
| 2013 Q4 | 4.96 Million USD | 9.75% |
| 2012 FY | 4.77 Million USD | -15.21% |
| 2012 Q1 | 5.69 Million USD | 1.03% |
| 2012 Q3 | 5.72 Million USD | -3.7% |
| 2012 Q2 | 5.94 Million USD | 4.32% |
| 2012 Q4 | 4.77 Million USD | -16.45% |
| 2011 Q4 | 5.63 Million USD | -4.34% |
| 2011 FY | 5.63 Million USD | -6.3% |
| 2011 Q3 | 5.89 Million USD | 0.05% |
| 2011 Q2 | 5.88 Million USD | -0.84% |
| 2011 Q1 | 5.93 Million USD | -1.26% |
| 2010 Q2 | 7.23 Million USD | 2.15% |
| 2010 Q3 | 6.83 Million USD | -5.58% |
| 2010 Q1 | 7.08 Million USD | 0.63% |
| 2010 Q4 | 6.01 Million USD | -11.96% |
| 2010 FY | 6.01 Million USD | -14.56% |
| 2009 Q4 | 7.04 Million USD | -7.6% |
| 2009 Q1 | 9.16 Million USD | 0.27% |
| 2009 Q2 | 8.58 Million USD | -6.27% |
| 2009 Q3 | 7.61 Million USD | -11.27% |
| 2009 FY | 7.04 Million USD | -22.94% |
| 2008 FY | 9.13 Million USD | -0.15% |
| 2008 Q3 | 9.87 Million USD | 8.14% |
| 2008 Q1 | 9.32 Million USD | 1.86% |
| 2008 Q4 | 9.13 Million USD | -7.46% |
| 2008 Q2 | 9.13 Million USD | -2.04% |
| 2007 Q2 | 9.33 Million USD | -1.85% |
| 2007 Q4 | 9.15 Million USD | -0.51% |
| 2007 FY | 9.15 Million USD | 1.47% |
| 2007 Q1 | 9.51 Million USD | 5.5% |
| 2007 Q3 | 9.19 Million USD | -1.5% |
| 2006 Q2 | 7.82 Million USD | 1.32% |
| 2006 Q1 | 7.72 Million USD | -2.66% |
| 2006 Q3 | 8.21 Million USD | 4.98% |
| 2006 Q4 | 9.01 Million USD | 9.71% |
| 2006 FY | 9.01 Million USD | 13.59% |
| 2005 Q2 | 8.04 Million USD | 3.27% |
| 2005 FY | 7.93 Million USD | -5.22% |
| 2005 Q4 | 7.93 Million USD | -7.9% |
| 2005 Q1 | 7.79 Million USD | -6.97% |
| 2005 Q3 | 8.61 Million USD | 7.12% |
| 2004 Q2 | 7.51 Million USD | -0.37% |
| 2004 Q1 | 7.53 Million USD | 11.21% |
| 2004 Q3 | 8.09 Million USD | 7.74% |
| 2004 Q4 | 8.37 Million USD | 3.51% |
| 2004 FY | 8.37 Million USD | 23.56% |
| 2003 FY | 6.77 Million USD | 20.01% |
| 2003 Q1 | 5.76 Million USD | 2.05% |
| 2003 Q3 | 7.17 Million USD | 22.84% |
| 2003 Q4 | 6.77 Million USD | -5.59% |
| 2003 Q2 | 5.84 Million USD | 1.39% |
| 2002 FY | 5.64 Million USD | 11.05% |
| 2002 Q2 | 5.25 Million USD | 6.72% |
| 2002 Q4 | 5.64 Million USD | -1.57% |
| 2002 Q1 | 4.92 Million USD | 0.0% |
| 2002 Q3 | 5.73 Million USD | 9.15% |
| 2001 Q2 | 3.69 Million USD | 1.46% |
| 2001 Q3 | 4.54 Million USD | 23.02% |
| 2001 Q1 | 3.64 Million USD | -8.1% |
| 2001 FY | 5.08 Million USD | 0.95% |
| 2000 Q1 | 5.03 Million USD | -2.91% |
| 2000 Q3 | 4.7 Million USD | -5.69% |
| 2000 Q2 | 4.99 Million USD | -0.95% |
| 2000 FY | 5.03 Million USD | 13.6% |
| 2000 Q4 | 3.96 Million USD | -15.83% |
| 1999 Q3 | 4.66 Million USD | 8.32% |
| 1999 Q2 | 4.3 Million USD | -3.0% |
| 1999 Q1 | 4.43 Million USD | -5.44% |
| 1999 FY | 4.43 Million USD | -17.87% |
| 1999 Q4 | 5.18 Million USD | 11.35% |
| 1998 Q4 | 4.69 Million USD | -18.87% |
| 1998 Q3 | 5.78 Million USD | 18.39% |
| 1998 Q2 | 4.88 Million USD | -9.57% |
| 1998 Q1 | 5.4 Million USD | 17.39% |
| 1998 FY | 5.4 Million USD | 31.49% |
| 1997 FY | 4.1 Million USD | 0.0% |
| 1997 Q4 | 4.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Arrayit Corporation | 1 Million USD | -26.851% |
| Atlantic International Corp. | 4.43 Million USD | 71.395% |
| Biocept, Inc. | 30.87 Million USD | 95.89% |
| Bioqual, Inc. | 56.58 Million USD | 97.757% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -447.143% |
| DermTech, Inc. | 121.93 Million USD | 98.959% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.97% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 92.862% |
| iMD Companies, Inc. | 190.13 Thousand USD | -567.413% |
| IDenta Corp. | 1.52 Million USD | 17.02% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 90.254% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 84.622% |
| InVitro International | 1.53 Million USD | 17.275% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 95.272% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -54787.543% |
| Medical Imaging Corp. | 4.19 Million USD | 69.725% |
| NovelStem International Corp. | 2.25 Million USD | 43.714% |
| Optigenex Inc. | 1.88 Million USD | 32.796% |
| PharmChem, Inc. | 2.76 Million USD | 54.114% |
| Proteome Sciences plc | 14.58 Million USD | 91.3% |
| Response Genetics, Inc | 48.88 Million USD | 97.404% |
| Rennova Health, Inc. | 20.57 Million USD | 93.832% |
| RushNet, Inc. | 6.04 Million USD | 79.016% |
| ScreenPro Security Inc. | 1.26 Million USD | -0.606% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -168.615% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -81.117% |
| Todos Medical Ltd. | 15.26 Million USD | 91.688% |